On Oct. 22, 2019, scientists at Sanford Burnham Prebys announced they had developed a machine-learning algorithm that gleans information from microscope images, allowing for high-throughput epigenetic drug screens that could unlock new treatments for cancer, heart disease, mental illness and more.